Canine distemper is a highly contagious viral disease that affects dogs and other carnivores, caused by the canine distemper virus (CDV), which belongs to the Paramyxoviridae family and the Morbillivirus genus. It is one of the most significant infectious diseases in veterinary clinical practice and public health, due to its high morbidity, mortality, and widespread global distribution.
CDV affects multiple organ systems, including the respiratory, digestive, nervous, and lymphatic systems. Transmission occurs primarily through aerosols and respiratory secretions from infected animals, but can also occur through contact with contaminated fomites. Young, unvaccinated, or immunosuppressed dogs are most susceptible to infection.
The clinical manifestations of distemper are varied and may progress gradually. Initial signs include fever, lethargy, eye and nasal discharge, coughing, and diarrhea. In more advanced stages, neurological signs such as seizures, myoclonus, paralysis, and behavioral changes may occur, often associated with a poor prognosis.
The prevention of distemper relies primarily on vaccination, which is considered the most effective measure for controlling the disease. Appropriate vaccination protocols, combined with biosecurity measures, population control, and the isolation of sick animals, are essential for reducing viral circulation.
Laboratory diagnosis is essential for confirming CDV infection. Molecular methods, such as RT-PCR, allow for the detection of the virus in secretions, blood, and tissues, while serological and immunohistochemical tests can aid in the complementary diagnosis. Early identification is critical for clinical management and epidemiological control.
Continuous epidemiological surveillance, combined with vaccination programs and health education, is essential for controlling canine distemper. These strategies help protect animal health, reduce mortality, and strengthen preventive measures in dog populations.
In this context, Bioperfectus’ rapid test for Canine Distemper Virus (CDV) serves as a practical screening tool to support clinical diagnosis and public health surveillance. The use of the rapid test enables the rapid identification of suspected cases directly at the veterinary clinic, allowing for the immediate implementation of measures such as isolation, early clinical management, and enhanced biosecurity, as well as referral for confirmation via laboratory methods when necessary. Thus, the rapid test complements conventional diagnostic techniques, contributing to the early detection of CDV, the reduction of virus spread, and the strengthening of canine distemper control strategies.
